Transatlantique Private Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,497
| Closed | -$247K | – | 215 |
|
|
2025
Q1 | $247K | Buy |
3,497
+47
| +1% | +$3.32K | 0.1% | 196 |
|
|
2024
Q4 | $227K | Sell |
3,450
-65
| -2% | -$4.27K | 0.09% | 193 |
|
|
2024
Q3 | $247K | Buy |
3,515
+128
| +4% | +$9K | 0.09% | 197 |
|
|
2024
Q2 | $270K | Sell |
3,387
-36
| -1% | -$2.87K | 0.11% | 175 |
|
|
2024
Q1 | $299K | Sell |
3,423
-34
| -1% | -$2.97K | 0.13% | 185 |
|
|
2023
Q4 | $333K | Sell |
3,457
-1,786
| -34% | -$172K | 0.16% | 175 |
|
|
2023
Q3 | $464K | Sell |
5,243
-52
| -1% | -$4.6K | 0.25% | 136 |
|
|
2023
Q2 | $459K | Buy |
5,295
+105
| +2% | +$9.1K | 0.24% | 139 |
|
|
2023
Q1 | $505K | Buy |
5,190
+672
| +15% | +$65.3K | 0.28% | 122 |
|
|
2022
Q4 | $466K | Sell |
4,518
-180
| -4% | -$18.6K | 0.28% | 109 |
|
|
2022
Q3 | $399K | Buy |
4,698
+50
| +1% | +$4.25K | 0.27% | 122 |
|
|
2022
Q2 | $385K | Buy |
+4,648
| New | +$385K | 0.27% | 137 |
|